Satomi Okano Selected Research

octyl-beta-D-glucoside (octyl glucoside)

1/2021

An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satomi Okano Research Topics

Disease

6	Neoplasms (Cancer) 02/2021 - 02/2018
3	Fibrosis (Cirrhosis) 01/2023 - 01/2012
3	Brain Diseases (Brain Disorder) 12/2021 - 03/2018
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2021
2	Critical Illness (Critically Ill) 01/2022 - 01/2019
2	Infections 01/2022 - 01/2020
1	Liver Diseases (Liver Disease) 01/2023
1	Cystic Fibrosis (Mucoviscidosis) 01/2023
1	Inflammation (Inflammations) 01/2022
1	Malaria 01/2022
1	Necrosis 01/2022
1	Insulin Resistance 01/2022
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Disease Progression 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Carcinogenesis 12/2020
1	Thrombosis (Thrombus) 12/2020
1	Arthritis (Polyarthritis) 10/2020
1	Pain (Aches) 10/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Ischemia 01/2020
1	Hypothermia 01/2020
1	Diabetes Mellitus 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 02/2018
1	Carcinoma (Carcinomatosis) 02/2018
1	Squamous Cell Carcinoma of Head and Neck 02/2018
1	Bone Fractures (Bone Fracture) 01/2018
1	Bone Diseases (Bone Disease) 01/2018
1	Myocardial Infarction 01/2017
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 01/2016
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2015
1	Obesity 01/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
2	AntibodiesIBA 01/2022 - 01/2020
2	Insulin (Novolin)FDA Link 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2012
2	Caveolin 1IBA 01/2021 - 01/2012
1	CC ChemokinesIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Fatty Acid-Binding ProteinsIBA 01/2023
1	LigandsIBA 01/2023
1	ChemokinesIBA 01/2023
1	Receptor for Advanced Glycation End ProductsIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Advanced Glycation End ProductsIBA 01/2022
1	Alkaline PhosphataseIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	early endosome antigen 1IBA 01/2021
1	Death-Associated Protein KinasesIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Ascorbate PeroxidasesIBA 01/2021
1	Golgi Matrix ProteinsIBA 01/2021
1	Maltose-Binding ProteinsIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	octyl-beta-D-glucoside (octyl glucoside)IBA 01/2021
1	Green Fluorescent ProteinsIBA 01/2021
1	CaveolinsIBA 01/2021
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	3,3'-Diaminobenzidine (3,3 Diaminobenzidine)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	DEAD-box RNA HelicasesIBA 12/2020
1	Monoclonal AntibodiesIBA 01/2020
1	AntiemeticsIBA 01/2020
1	XenonIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Prochlorperazine (Compazine)FDA LinkGeneric 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2019
1	CarbohydratesIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	Cetuximab (Erbitux)FDA Link 02/2018
1	titanium fiberIBA 01/2018
1	matrigelIBA 01/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2015

Therapy/Procedure

3	Induced Hypothermia 12/2021 - 03/2018
2	Therapeutics 02/2018 - 01/2016
1	Critical Care (Surgical Intensive Care) 12/2021
1	Metastasectomy 02/2021
1	Catheters 12/2020
1	Treatment Delay 10/2020
1	Rewarming 01/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Fontan Procedure (Fontan Operation) 01/2016